The influence of muscarinic acetylcholine receptors (M1, M4 and M5) and serotonergic 5-HT1A receptor modulation on cognitive deficits in animal model of schizophrenia.

2018/31/N/NZ7/03646

Keywords

Descriptors

  • NZ7_14: Farmacja, farmakoterapia, farmakologia
  • NZ7_16: Inne zagadnienia pokrewne

Panel

NZ7 – Diagnostic tools, therapies and public health: public health, epidemiology, environmental health risks and occupational medicine, medical ethics, drug discovery and therapies, pharmacology

Host institution

Instytut Farmakologii PAN

Voivodeship: małopolskie

Other projects carried out by the institution »

Principal investigator (from the host institution)

dr Paulina Agnieszka Cieślik

Number of co-investigators in the project: 2

Call

PRELUDIUM 16 – announced on 2018-09-14

Amount awarded
210 000 PLN
Project start date
2019-08-07
Project end date
2022-08-06
Project duration
36 months (the same as in the proposal)
Project status
Project settled

Project description

Download the project description in a pdf file

Note — project descriptions were prepared by the authors of the applications themselves and placed in the system in an unchanged form.

Information in the final report

Publication in academic press/journals (1)

  1. Serotonergic-Muscarinic Interaction within the Prefrontal Cortex as a Novel Target to Reverse Schizophrenia-Related Cognitive Symptoms

    Authors:
    Cieślik Paulina, Radulska Adrianna, Burnat Grzegorz, Kalinowski Leszek, Wierońska Joanna M
    Academic press:
    International journal of molecular sciences (year: 2021, volume: 22, pages: 8612), Publisher: Multidisciplinary Digital Publishing Institute
    Status:
    Published
    DOI:
    10.3390/ijms22168612 – link to the publication

« New search

Graphic design and implementation: Jakub Piotrowski